Covered recipient · General Payments record
CLAUS J FIMMEL
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$2,068.51
- Reported across 19 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $176.53 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Gilead Sciences, Inc. | $46.65 | 2 |
| Madrigal Pharmaceuticals | $38.90 | 2 |
| INTERCEPT PHARMACEUTICALS, INC. | $28.79 | 1 |
| Ipsen Biopharmaceuticals, Inc | $25.88 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.84 | 1 |
| Braintree Laboratories, Inc. | $16.47 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Braintree Laboratories, Inc. | $16.47 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125514361 | CMS |
| Gilead Sciences, Inc. | $20.35 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133783751 | CMS |
| Gilead Sciences, Inc. | $26.30 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133783753 | CMS |
| Intercept Pharmaceuticals, Inc. | $28.79 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113632104 | CMS |
| Ipsen Biopharmaceuticals, Inc | $25.88 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091990316 | CMS |
| Madrigal Pharmaceuticals | $21.25 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144165819 | CMS |
| Madrigal Pharmaceuticals | $17.65 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144165821 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.84 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137547469 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2020 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.